79 related articles for article (PubMed ID: 19807388)
1. Risk-adjusted capitation payment systems for health insurance plans in a competitive market.
Lamers LM; van Vliet RC; van de Ven WP
Expert Rev Pharmacoecon Outcomes Res; 2003 Oct; 3(5):541-9. PubMed ID: 19807388
[TBL] [Abstract][Full Text] [Related]
2. Managing risk selection incentives in health sector reforms.
Puig-Junoy J
Int J Health Plann Manage; 1999; 14(4):287-311. PubMed ID: 11184915
[TBL] [Abstract][Full Text] [Related]
3. Mandatory high-risk pooling: an approach to reducing incentives for cream skimming.
van Barneveld EM; van Vliet RC; van de Ven WP
Inquiry; 1996; 33(2):133-43. PubMed ID: 8675277
[TBL] [Abstract][Full Text] [Related]
4. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.
Lamers LM
Health Policy; 1998 Jul; 45(1):15-32. PubMed ID: 10183010
[TBL] [Abstract][Full Text] [Related]
5. Optimal risk adjustment with adverse selection and spatial competition.
Jack W
J Health Econ; 2006 Sep; 25(5):908-26. PubMed ID: 16712986
[TBL] [Abstract][Full Text] [Related]
6. New payment model for rural health services in Mongolia.
Hindle D; Khulan B
Rural Remote Health; 2006; 6(1):434. PubMed ID: 16460229
[TBL] [Abstract][Full Text] [Related]
7. The impact of health insurance market reforms on market competition.
Hall MA
Am J Manag Care; 2000 Jan; 6(1):57-67. PubMed ID: 11009747
[TBL] [Abstract][Full Text] [Related]
8. Risk-adjusted capitation: recent experiences in The Netherlands.
van de Ven WP; van Vliet RC; van Barneveld EM; Lamers LM
Health Aff (Millwood); 1994; 13(5):120-36. PubMed ID: 7868016
[TBL] [Abstract][Full Text] [Related]
9. Pharmacy costs groups: a risk-adjuster for capitation payments based on the use of prescribed drugs.
Lamers LM
Med Care; 1999 Aug; 37(8):824-30. PubMed ID: 10448725
[TBL] [Abstract][Full Text] [Related]
10. Free choice of health plan combined with risk-adjusted capitation payments: are switchers and new enrolees good risks?
van Vliet RC
Health Econ; 2006 Aug; 15(8):763-74. PubMed ID: 16498705
[TBL] [Abstract][Full Text] [Related]
11. Exposing the true risks of capitation financed healthcare.
Cox T
J Healthc Risk Manag; 2011; 30(4):34-41. PubMed ID: 21506200
[TBL] [Abstract][Full Text] [Related]
12. Cream-skimming, incentives for efficiency and payment system.
Barros PP
J Health Econ; 2003 May; 22(3):419-43. PubMed ID: 12683960
[TBL] [Abstract][Full Text] [Related]
13. Risk selection in the health care market: a workshop overview.
Gauthier AK; Lamphere JA; Barrand NL
Inquiry; 1995; 32(1):14-22. PubMed ID: 7713613
[TBL] [Abstract][Full Text] [Related]
14. Preferences and choices for care and health insurance.
van den Berg B; Van Dommelen P; Stam P; Laske-Aldershof T; Buchmueller T; Schut FT
Soc Sci Med; 2008 Jun; 66(12):2448-59. PubMed ID: 18400349
[TBL] [Abstract][Full Text] [Related]
15. Mandatory pooling as a supplement to risk-adjusted capitation payments in a competitive health insurance market.
Van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
Soc Sci Med; 1998 Jul; 47(2):223-32. PubMed ID: 9720641
[TBL] [Abstract][Full Text] [Related]
16. Prior health expenditures and risk sharing with insurers competing on quality.
Marchand M; Sato M; Schokkaert E
Rand J Econ; 2003; 34(4):647-69. PubMed ID: 14992229
[TBL] [Abstract][Full Text] [Related]
17. Is there a business case for quality in The Netherlands? A critical analysis of the recent reforms of the health care system.
Custers T; Arah OA; Klazinga NS
Health Policy; 2007 Jul; 82(2):226-39. PubMed ID: 17070956
[TBL] [Abstract][Full Text] [Related]
18. Risk adjustment and risk selection in Europe: 6 years later.
van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
[TBL] [Abstract][Full Text] [Related]
19. A method for risk-adjusting employer contributions to competing health insurance plans.
Robinson JC; Luft HS; Gardner LB; Morrison EM
Inquiry; 1991; 28(2):107-16. PubMed ID: 1829709
[TBL] [Abstract][Full Text] [Related]
20. The legal framework for effective competition.
Berenson RA; Hastings DA; Kopit WG
Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
